Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Furoate/Vilanterol vs Fluticasone Propionate/Salmeterol in Persistent Asthma
NCT01147848Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of fluticasone furoate + vilanterol in asthma (2 arms), sponsored by GSK. Primary endpoint: Change From Baseline in Weighted-mean 24 Hour Serial FEV1 on Day 168/Week 24. Started Jun 2010; status: completed.
02
Drugs
fluticasone furoate + vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01147848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01147848.